Clinical Trial Update: Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects [NA]

View source ↗

Summary

This clinical trial evaluated Akkermansia muciniphila Akk11 for metabolic and gut health in adults who are overweight or obese; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Akkermansia muciniphila Akk11 (Akkermansia muciniphila Akk11)

Snippet

Sponsor: Wecare Probiotics Co., Ltd. | Conditions: Overweight or Obesity | NA | Status: COMPLETED